rifamycins

Susceptibility
Activities of Rifamycin Derivatives against Wild-Type and rpoB Mutants of Chlamydia trachomatis
Minsheng Xia, Robert J. Suchland, Joli A. Carswell, John Van Duzer, Debra K. Buxton, Kara Brown, David M. Rothstein, Walter E. Stamm
Susceptibility
Rifampin-Resistant RNA Polymerase Mutants of Chlamydia trachomatis Remain Susceptible to the Ansamycin Rifalazil
Robert J. Suchland, Agnès Bourillon, Erick Denamur, Walter E. Stamm, David M. Rothstein
Mechanisms of Resistance
Emergence of Resistance to Rifampin and Rifalazil in Chlamydophila pneumoniae and Chlamydia trachomatis
Andrei Kutlin, Stephan Kohlhoff, Patricia Roblin, Margaret R. Hammerschlag, Paul Riska
Experimental Therapeutics
Rifalazil Treats and Prevents Relapse of Clostridium difficile-Associated Diarrhea in Hamsters
Pauline M. Anton, Michael O'Brien, Efi Kokkotou, Barry Eisenstein, Arthur Michaelis, David Rothstein, Sophia Paraschos, Ciáran P. Kelly, Charalabos Pothoulakis
GUEST COMMENTARY
Treatment of Chronic Infections with Rifamycins: Is Resistance Likely To Follow?
Richard E. Chaisson
Susceptibility
In Vitro Activities of Rifamycin Derivatives ABI-1648 (Rifalazil, KRM-1648), ABI-1657, and ABI-1131 against Chlamydia trachomatis and Recent Clinical Isolates of Chlamydia pneumoniae
Patricia M. Roblin, Tamara Reznik, Andrei Kutlin, Margaret R. Hammerschlag
Clinical Therapeutics
Safety and Bactericidal Activity of Rifalazil in Patients with Pulmonary Tuberculosis
Reynaldo Dietze, Luciléia Teixeira, Lia Márcia Canedo Rocha, Moisés Palaci, John L. Johnson, Charles Wells, Lynn Rose, Kathleen Eisenach, Jerrold J. Ellner
LETTERS TO THE EDITOR
In Vitro Activity of Rifaximin against Enteropathogens Producing Traveler's Diarrhea
Josep M. Sierra, Joaquin Ruiz, Margarita M. Navia, Martha Vargas, Joaquim Gascon, Jordi Vila
Experimental Therapeutics
Evaluation of Rifalazil in a Combination Treatment Regimen as an Alternative to Isoniazid-Rifampin Therapy in a Mouse Tuberculosis Model
Anne M. Lenaerts, Sharon E. Chase, Michael H. Cynamon
Pharmacology
In Vitro Activity and Fecal Concentration of Rifaximin after Oral Administration
Zhi-Dong Jiang, Shi Ke, Ernesto Palazzini, Lise Riopel, Herbert Dupont

Main menu

User menu

Search

rifamycins

Pages